These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2342067)

  • 1. Highly active and selective anticoagulants: D-Phe-Pro-Arg-H, a free tripeptide aldehyde prone to spontaneous inactivation, and its stable N-methyl derivative, D-MePhe-Pro-Arg-H.
    Bajusz S; Szell E; Bagdy D; Barabas E; Horvath G; Dioszegi M; Fittler Z; Szabo G; Juhasz A; Tomori E
    J Med Chem; 1990 Jun; 33(6):1729-35. PubMed ID: 2342067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro inhibition of blood coagulation by tripeptide aldehydes--a retrospective screening study focused on the stable D-MePhe-Pro-Arg-H.H2SO4.
    Bagdy D; Barabás E; Bajusz S; Széll E
    Thromb Haemost; 1992 Mar; 67(3):325-30. PubMed ID: 1641823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active site-directed thrombin inhibitors: alpha-hydroxyacyl-prolyl-arginals. New orally active stable analogs of D-Phe-Pro-Arg-H.
    Bajusz S; Barabás E; Fauszt I; Fehér A; Horváth G; Juhász A; Szabó AG; Széll E
    Bioorg Med Chem; 1995 Aug; 3(8):1079-89. PubMed ID: 7582981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active site-directed thrombin inhibitors: alpha-hydroxyacyl-prolyl-arginals, new orally active stable analogues of D-Phe-Pro-Arg-H.
    Bajusz S; Barabas E; Fauszt I; Feher A; Horvath G; Juhasz A; Szabo GA; Szell E
    Semin Thromb Hemost; 1996; 22(3):243-6. PubMed ID: 8836008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinolytic compromise by simultaneous administration of site-directed inhibitors of thrombin.
    Callas D; Bacher P; Iqbal O; Hoppensteadt D; Fareed J
    Thromb Res; 1994 May; 74(3):193-205. PubMed ID: 8042188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
    Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
    J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity study of tripeptide thrombin inhibitors using alpha-alkyl amino acids and other conformationally constrained amino acid substitutions.
    Shuman RT; Rothenberger RB; Campbell CS; Smith GF; Gifford-Moore DS; Paschal JW; Gesellchen PD
    J Med Chem; 1995 Oct; 38(22):4446-53. PubMed ID: 7473571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo anticoagulant and antiplatelet effect of D-Phe-Pro-Arg-H and D-MePhe-Pro-Arg-H.
    Bagdy D; Barabás E; Szabó G; Bajusz S; Széll E
    Thromb Haemost; 1992 Mar; 67(3):357-65. PubMed ID: 1641827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of peptide inhibitors of blood coagulations.
    Bajusz S; Széll E; Barabás E; Bagdy D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):16-21. PubMed ID: 6177598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for fibrinolysis inhibitory effect of synthetic thrombin inhibitors.
    Barabas E; Szell E; Bajusz S
    Blood Coagul Fibrinolysis; 1993 Apr; 4(2):243-8. PubMed ID: 8499562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemistry and biology of the peptide anticoagulant D-MePhe-Pro-Arg-H (GYKI-14766).
    Bajusz S
    Adv Exp Med Biol; 1993; 340():91-108. PubMed ID: 8154347
    [No Abstract]   [Full Text] [Related]  

  • 12. Highly selective tripeptide thrombin inhibitors.
    Shuman RT; Rothenberger RB; Campbell CS; Smith GF; Gifford-Moore DS; Gesellchen PD
    J Med Chem; 1993 Feb; 36(3):314-9. PubMed ID: 8426361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the contractile action of bradykinin on isolated smooth muscle preparations by derivatives of low molecular weight peptides.
    Claeson G; Fareed J; Larsson C; Kindel G; Arielly S; Simonsson R; Messmore HL; Balis JU
    Adv Exp Med Biol; 1979; 120B():691-713. PubMed ID: 517262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and structure-activity relationship of a series of arginine aldehyde factor Xa inhibitors. Part 1: structures based on the (D)-Arg-Gly-Arg tripeptide sequence.
    Marlowe CK; Sinha U; Gunn AC; Scarborough RM
    Bioorg Med Chem Lett; 2000 Jan; 10(1):13-6. PubMed ID: 10636232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptides and pseudopeptides incorporating D-Phe-Pro-Arg and Arg-Gly-Asp lead sequences as potential antithrombotic agents.
    Ilas J; Hudecz F; Süli-Vargha H; Kikelj D
    J Pept Sci; 2008 Aug; 14(8):946-53. PubMed ID: 18383437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical effect and kinetics of thrombin inhibition by GYKI-14766.
    Bakonyi A; Kovács L; Duong HT; Arányi P
    Acta Physiol Hung; 1994; 82(1):29-36. PubMed ID: 7976393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition by D-MePhe-Pro-Arg-H (GYKI-14766) of thrombus growth in experimental models of thrombosis.
    Bagdy D; Szabó G; Barabás E; Bajusz S
    Thromb Haemost; 1992 Aug; 68(2):125-9. PubMed ID: 1412156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new series of photoactivatable and iodinatable linear vasopressin antagonists.
    Carnazzi E; Aumelas A; Barberis C; Guillon G; Seyer R
    J Med Chem; 1994 Jun; 37(12):1841-9. PubMed ID: 8021923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative studies in vitro and ex vivo on the anticoagulant effect of a reversible and an irreversible tripeptide inhibitor of thrombin.
    Bagdy D; Barabás E; Bajusz S; Széll E; Fehér A
    Thromb Res; 1992 Jul; 67(2):221-31. PubMed ID: 1440524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of S18326 as a new potent and selective boronic acid direct thrombin inhibitor.
    Rupin A; Mennecier P; Lila C; de Nanteuil G; Verbeuren TJ
    Thromb Haemost; 1997 Oct; 78(4):1221-7. PubMed ID: 9364988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.